Peter J. Flor

Peter J. Flor


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
DPDaniel Peterlik
Daniel Peterlik
PFPeter J. Flor
Peter J. Flor
NUNicole Uschold-Schmidt
Nicole Uschold-Schmidt
Chronic stress-related psychiatric conditions such as anxiety, depression, and alcohol abuse are an enormous public health concern. The etiology of these pathologies is complex, with psychosocial stressors being among the most frequently discussed risk factors. The brain glutamatergic neurotransmitter system has often been found involved in behaviors and pathophysiologies resulting from acute stress and fear. Despite this, relatively little is known about the role of glutamatergic system components in chronic psychosocial stress, neither in rodents nor in humans. Recently, drug discovery efforts at the metabotropic receptor subtypes of the glutamatergic system (mGlu1-8 receptors) led to the identification of pharmacological tools with emerging potential in psychiatric conditions. But again, the contribution of individual mGlu subtypes to the manifestation of physiological, molecular, and behavioral consequences of chronic psychosocial stress remains still largely unaddressed. The current review will describe animal models typically used to analyze acute and particularly chronic stress conditions, including models of psychosocial stress, and there we will discuss the emerging roles for mGlu receptor subtypes. Indeed, accumulating evidence indicates relevance and potential therapeutic usefulness of mGlu2/3 ligands and mGlu5 receptor antagonists in chronic stress-related disorders. In addition, a role for further mechanisms, e.g. mGlu7-selective compounds, is beginning to emerge. These mechanisms are important to be analyzed in chronic psychosocial stress paradigms, e.g. in the chronic subordinate colony housing (CSC) model. We summarize the early results and discuss necessary future investigations, especially for mGlu5 and mGlu7 receptor blockers, which might serve to suggest improved therapeutic strategies to treat stress-related disorders.

1 January 2017 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
DPDaniel Peterlik
Daniel Peterlik
CSChristina Stangl
Christina Stangl
ABAmelie Bauer
Amelie Bauer
ABAnna Bludau
Anna Bludau
JKJana Keller
Jana Keller
NUNicole Uschold-Schmidt
Nicole Uschold-Schmidt

1 March 2017 in Neuropharmacology
Verified
Journal Article
Closed access
DPDaniel Peterlik
Daniel Peterlik
CSChristina Stangl
Christina Stangl
ABAnna Bludau
Anna Bludau
DGDominik Grabski
Dominik Grabski
RSRobert Strasser
Robert Strasser
NUNicole Uschold-Schmidt
Nicole Uschold-Schmidt


2 June 2022 in Cells
Verified
Journal Article
Open access
PDF file
KEKarolyne A. R. Estrela
Karolyne A. R. Estrela
LSLisa Senninger
Lisa Senninger
JAJosephine Arndt
Josephine Arndt
MKMelanie Kabas
Melanie Kabas
FSFerdinand Schmid
Ferdinand Schmid
NUNicole Uschold-Schmidt
Nicole Uschold-Schmidt
Chronic psychosocial stress participates prominently in the etiology of various psychiatric conditions and comorbid somatic pathologies; however, suitable pharmacotherapy of these disorders is still of high medical need. During the last few decades, research on mGlu receptors advanced remarkably and much attention was given to the mGlu7 subtype. Here, genetic mGlu7 ablation, short-term pharmacological mGlu7 blockade, as well as siRNA-mediated knockdown of mGlu7 were shown to result in an acute anti-stress, antidepressant- and anxiolytic-like phenotype in mice. Moreover, we recently revealed a prominent stress-protective effect of genetic mGlu7 ablation also with respect to chronic psychosocial stress. In addition, we are able to demonstrate in the present study that the chronic pharmacological blockade of mGlu7 interferes with various chronic stress-induced alterations. For this, we used the chronic subordinate colony housing (CSC), a mouse model of chronic male subordination, in combination with chronic treatment with the mGlu7-selective orthosteric-like antagonist XAP044 (7-hydroxy-3-(4-iodophenoxy)-4H-chromen-4-one). Interestingly, XAP044 dose-dependently ameliorates hypothalamic–pituitary–adrenal axis dysfunctions, thymus atrophy, as well as the CSC-induced increase in innate anxiety. Taken together, our findings provide further evidence for the role of mGlu7 in chronic psychosocial stress-induced alterations and suggests the pharmacological blockade of mGlu7 as a promising therapeutic approach for the treatment of chronic stress-related pathologies in men.